Damage-induced pyroptosis drives endogenous thymic regeneration by activating the purinergic receptor P2Y2

Read full text
Authors: Sinead M. Kinsella, Cindy Evandy, Kirsten Cooper, Erin Kirsche, Makya Warren, Paul C. DeRoos, Antonella Cardinale, Lorenzo Iovino, David W. Granadier, Colton W Smith, Kayla S. Hopwo, Lucas B. Sullivan
+2 more Enrico Velardi, Jarrod A. Dudakov
Cited by: 0
References: 78

Abstract

T cell recovery is critical following damage, such as hematopoietic cell transplantation (HCT), with increased reconstitution associated with improved clinical outcomes. Endogenous thymic regeneration, a crucial process for restoring immune competence following cytoreductive therapies such as HCT conditioning, is often delayed, limiting T cell reconstitution. Fully understanding the molecular mechanisms driving regeneration is therefore crucial for uncovering therapeutic targets that can be exploited to enhance thymic function. Here, we identified that CD4+ CD8+ thymocytes rapidly and acutely undergo lytic cell death, specifically pyroptosis, following acute damage caused by ionizing radiation, and release damage-associated molecular patterns (DAMPS) into the thymic microenvironment, including ATP. Extracellular ATP stimulates the P2Y2 purinergic receptor on thymic epithelial cells (TECs)-a stromal cell crucial for supporting T cell development-resulting in the upregulation FOXN1, the master TEC transcription factor. Targeting the P2Y2 receptor with a P2Y2 agonist, UTPγS, promotes rapid regeneration of the TEC compartment in vivo following acute damage. These findings reveal a novel damage-sensing mechanism employed by the thymus where thymocytes adopt an alternative cell death mechanism which promotes thymic repair via P2Y2 signaling in TECs. This work identifies P2Y2 as a promising therapeutic target for enhancing thymus regeneration and improving immune recovery after HCT.

Fields of Study & Subjects

Adenosine and Purinergic Signaling Inflammasome and immune disorders Immune cells in cancer

Publication details

Journal / source
Cell Death and Disease
Volume
17
Issue
1
Pages
157–157
Publication date
3 January 2026
Language
EN